COMP <GO>
STE vs ALGN // 10Y YIELD & FRED MACRO BETA
STERIS plc (Ireland) (NYSE) VS. Align Technology Inc. (NASDAQ) • 15-METRIC TALLY: STE 9
— ALGN 4
▲ 10Y YIELD & FRED MACRO BETA LEADER: STE
LAST: $227.12 (-2.16%) • MKT CAP: $22.14B
macro-sensitivity
1.08
LAST: $149.89 (-2.48%) • MKT CAP: $10.65B
macro-sensitivity
0.90
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STE VS. ALGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STE | ALGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.20% | 67.20% | -23.00 | ALGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 11.10% | -1.00 | ALGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 17.0x | 0.00 | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.30% | 4.49% | -0.19 | ALGN | /fcf-yield <GO> |
| Operating Margin | 18.60% | 13.50% | +5.10 | STE | /operating-margins <GO> |
| Net Profit Margin | 13.20% | 10.20% | +3.00 | STE | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | 0.90% | +7.80 | STE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.07% | 0.00% | +1.07 | STE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.40 | 4.62 | +0.78 | STE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | STE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.4 | 49.0 | +5.40 | STE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.08 | 0.90 | +0.18 | STE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.9x | 24.7x | +2.20 | ALGN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.14B | $10.65B | $11.50B | STE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STE REV | ALGN REV | STE GROSS % | ALGN GROSS % | STE FCF | ALGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.94B | $4.03B | 44.2% | 67.2% | $972.4M | $490.8M |
| FY 2024 | $5.46B | $4.00B | — | 70.0% | $778.0M | $622.7M |
| FY 2023 | $5.14B | $3.86B | — | — | $742.1M | $612.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STE // BETA 1.08
ALGN // BETA 0.90